Radiopharmaceuticals testing expertise
Pharmatest has tested efficacy of radiopharmaceuticals in preclinical efficacy models since 2010. Pharmatest has performed a large amount of studies and acquired special expertise in testing α-emitters such as Ra-223, Ra-224, Th-227 and Ac-225. Many of these studies have been published in highly ranked scientific Journals and as poster presentations in leading scientific events. Below you can find some selected publications from studies performed at Pharmatest:
Our modernly equipped laboratories have been certified by the Radiation and Nuclear Safety Authorities in Finland, and we have licenses for handling radioactive materials in our laboratory. We can label your radioactive compounds for example with antibody conjugates, and confirm the labeling efficiency with basic methods.
Many of our routinely used techniques such as hematology, serum biomarker analysis and histology can be performed with radioactive samples. We can take care of the shipment of your compound, and we can also arrange the shipment of radioactive samples collected during the study to our clients for further analysis.